Keratinocyte Overexpression of IL-17C Promotes Psoriasiform Skin Inflammation
Open accessThe DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
IL-17C is a functionally distinct member of the IL-17 family that binds IL-17 receptor E/A to promote innate defense in epithelial cells and regulate Th17 cell differentiation. We demonstrate that IL-17C (not IL-17A) is the most abundant IL-17 isoform in lesional psoriasis skin (1058 versus 8 pg/ml; p < 0.006) and localizes to keratinocytes (KCs), endothelial cells (ECs), and leukocytes. ECs stimulated with IL-17C produce increased TNF-α and KCs stimulated with IL-17C/TNF-α produce similar inflammatory gene response patterns as those elicited by IL-17A/TNF-α, including increases in IL-17C, TNF-α, IL-8, IL-1α/β, IL-1F5, IL-1F9, IL-6, IL-19, CCL20, S100A7/A8/A9, DEFB4, lipocalin 2, and peptidase inhibitor 3 (p < 0.05), indicating a positive proinflammatory feedback loop between the epidermis and ECs. Psoriasis patients treated with etanercept rapidly decrease cutaneous IL-17C levels, suggesting IL-17C/TNF-α-mediated inflammatory signaling is critical for psoriasis pathogenesis. Mice genetically engineered to overexpress IL-17C in KCs develop well-demarcated areas of erythematous, flakey involved skin adjacent to areas of normal-appearing uninvolved skin despite increased IL-17C expression in both areas (p < 0.05). Uninvolved skin displays increased angiogenesis and elevated S100A8/A9 expression (p < 0.05) but no epidermal hyperplasia, whereas involved skin exhibits robust epidermal hyperplasia, increased angiogenesis and leukocyte infiltration, and upregulated TNF-α, IL-1α/β, IL-17A/F, IL-23p19, vascular endothelial growth factor, IL-6, and CCL20 (p < 0.05), suggesting that IL-17C, when coupled with other proinflammatory signals, initiates the development of psoriasiform dermatitis. This skin phenotype was significantly improved following 8 wk of TNF-α inhibition. These findings identify a role for IL-17C in skin inflammation and suggest a pathogenic function for the elevated IL-17C observed in lesional psoriasis skin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-17C can drive psoriatic inflammation in mouse models”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Johnston et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
Mease, P. J., Goffe, B. S., Metz, J., VanderStoep, A., Finck, B., & Burge, D. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02530-7 · Cited by 1,446
Functional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289
Etanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suárez-Fariñas, M., Cardinale, I., Khatcherian, A., Gonzalez, J., Pierson, K. C., White, T. R., et al. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08769.x · Cited by 804
Chiricozzi, A., Guttman-Yassky, E., Suárez-Fariñas, M., Nograles, K. E., Tian, S., Cardinale, I., Chimenti, S., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.340 · Cited by 686
IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
Ramirez-Carrozzi, V., Sambandam, A., Luis, E., Lin, Z., Jeet, S., Lesch, J., Hackney, J., Kim, J., Zhou, M., Lai, J., et al. (2011) · Nature Immunology · doi:10.1038/ni.2156 · Cited by 477
A Randomized Trial of Etanercept as Monotherapy for Psoriasis
Gottlieb, A. B. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.12.1627 · Cited by 470
Research works printed but not linked: 1
- Russell CB Kerkof K Bigler J Timour M Diaz RL Symons A Rand H Krueger JG Martin DA IL-17 Receptor A subunit is a central hub for inflammatory signaling in human psoriasis Journal of Investigative Dermatology 2012 132 S7
Cited by
Items 201–300 of 309
Management of youth psoriatic arthritis with etanercept: a case report
Bezerra-Santos, C. R., Palitot, E. B., Brito, G., & Braz, A. D. S. (2018) · Medical Research Archives · doi:10.18103/mra.v6i12.1874 · Cited by 11
Predicted regulatory SNPs reveal potential drug targets and novel companion diagnostics in psoriasis
Ramírez, A. V. R., Farias, A. F.-S., Álvarez, R. D. C. C., & de, E. P. M. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100096 · Cited by 15
Zhou, X., Jiang, X., Zhang, G., Ji, W., Shi, Z.-C., Ma, X., & Wei, K.-J. (2022) · Aquaculture · doi:10.1016/j.aquaculture.2022.737962 · Cited by 9
Morizane, S., Nomura, H., Tachibana, K., Nakagawa, Y., & Iwatsuki, K. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16443 · Cited by 15
Exploring the Diverse Immune and Genetic Landscape of Psoriatic Arthritis
Batko, B. P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245926 · Cited by 12
A Review Article on Brodalumab in the Treatment of Moderate-To-Severe Plaque Psoriasis
Roostaeyan, O., Kivelevitch, D. N., & Menter, A. (2017) · Immunotherapy · doi:10.2217/imt-2017-0077 · Cited by 11
Numata, T., Yoshizaki, T., Yamaguchi, S., Shimura, E., Iwakura, Y., Harada, K., Sudo, K., Tsuboi, R., & Nakae, S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.104 · Cited by 10
Ribes nigrum Leaf Extract Preferentially Inhibits IFN-γ-Mediated Inflammation in HaCaT Keratinocytes
Magnavacca, A., Piazza, S., Cammisa, A., Fumagalli, M., Martinelli, G., Giavarini, F., Sangiovanni, E., & Dell'agli, M. (2021) · Molecules · doi:10.3390/molecules26103044 · Cited by 9
Farzeen, I., Muzammil, S., Rafique, A., Noreen, R., Waseem, M., Andleeb, R., Ijaz, M. U., & Ashraf, A. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.107900 · Cited by 10
Nam, Y. J., Kim, A., Lee, M. S., Sohn, D. S., & Lee, C. S. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.09.014 · Cited by 10
IL-17C as a Driver of Inflammation in Psoriasis
Han, G., Armstrong, A. W., Krueger, J. G., & Jacobson, A. A. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03363-9 · Cited by 10
Liyanage, D. S., Omeka, W. K. M., Yang, H., Lim, C., Choi, C. Y., & Lee, J. (2021) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2021.110669 · Cited by 9
Cannizzaro, M. V., Coscarella, G., & Chiricozzi, A. (2023) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1303a245 · Cited by 10
Genome-wide DNA methylation mediates the resistance to vibriosis in Cynoglossus semilaevis
Ma, X., Chen, Q., Chen, Z., Chen, S., & Zhou, Q. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.109144 · Cited by 9
Evaluation of IL-17D in Host Immunity to Group A Streptococcus Infection
Washington, A., Varki, N. M., Valderrama, J. A., Nizet, V., & Bui, J. D. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901482 · Cited by 11
Zheng, N., Zhang, L., Wang, B., Wang, G., Liu, J., Miao, G., Zhao, X., Liu, C., & Zhang, L. (2019) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2019.151340 · Cited by 10
Pätzold, L., Stark, A., Ritzmann, F., Meier, C., Tschernig, T., Reichrath, J., Bals, R., Bischoff, M., & Beißwenger, C. (2021) · Microorganisms · doi:10.3390/microorganisms9091821 · Cited by 12
Wang, Y., Li, S., Bai, J., Cai, X., Tang, S., Lin, P., Sun, Q., Qiao, J., & Fang, H. (2023) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223231163110 · Cited by 8
Malik, B., Vokic, I., Mohr, T. T., Poppelaars, M., Holcmann, M., Novoszel, P., Timelthaler, G., Lendl, T., Krauß, D., Elling, U., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202216758 · Cited by 6
Airway epithelial development and function: A key player in asthma pathogenesis?
Chatziparasidis, G., Bush, A., Chatziparasidi, M. R., & Kantar, A. (2023) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2023.04.005 · Cited by 10
Lebwohl, M., Armstrong, A. W., Alexis, A. F., Lain, E. L., & Jacobson, A. A. (2024) · Dermatology and Therapy · doi:10.1007/s13555-024-01264-3 · Cited by 9
Targeting IL-17 with Ixekizumab in Patients with Psoriasis
Dyring‐Andersen, B., Skov, L., & Zachariae, C. O. C. (2015) · Immunotherapy · doi:10.2217/imt.15.63 · Cited by 8
Molecular and cellular regulation of psoriatic inflammation
Macleod, T., Bridgewood, C., Hyde, I., Heague, M., Helliwell, P., Stacey, M. A., & Wittmann, M. (2022) · Clinical Science · doi:10.1042/cs20210916 · Cited by 8
Ullah, R., Khan, J., Basharat, N., Huo, D., Din, A. U., & Wang, G. (2022) · Viruses · doi:10.3390/v14102149 · Cited by 11
Zhang, J., Shu, J., Sun, H., Zhai, T., Li, H., Li, H., Sun, Y., Huo, R., Shen, B., & Sheng, H. (2022) · The Journal of Dermatology · doi:10.1111/1346-8138.16611 · Cited by 9
Use of Brodalumab for the Treatment of Psoriasis and Psoriatic Arthritis
Kivelevitch, D. N., & Menter, A. (2015) · Immunotherapy · doi:10.2217/imt.14.113 · Cited by 11
Lebowitz, E., & Lebwohl, M. (2019) · SKIN The Journal of Cutaneous Medicine · doi:10.25251/skin.3.2.39 · Cited by 8
Youn, S. W., Jo, S. J., Park, C. J., Kim, D. H., Shin, B. S., Jeong, K., Bang, C. H., Cross, N., Thirlwell, J., & Hoepken, B. (2024) · The Journal of Dermatology · doi:10.1111/1346-8138.17446 · Cited by 9
Skin immunity and inflammation: cellular interactions and communication
Narayanan, D., Sim, S.-L., & Kumari, S. (2025) · Clinical & Translational Immunology · doi:10.1002/cti2.70053 · Cited by 10
Increased expression of the p-STAT3/IL-17 signaling pathway in patients with dermatomyositis
Li, D., Jia, W., Zhou, L., Hao, Y., Wang, K., Yang, B., Yang, J., Luo, D., & Fu, Z. (2022) · Modern Rheumatology · doi:10.1093/mr/roac147 · Cited by 9
IL-17 family cytokines in inflammatory or autoimmune skin diseases
Kong, B., & Lai, Y. (2024) · Advances in immunology · doi:10.1016/bs.ai.2024.07.002 · Cited by 8
Regulation of Interleukin-17 Production
Dong, W., & Ma, X. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-0921-5_7 · Cited by 7
Speed of Psoriasis Treatment Response for Biologic Agents: A Review of Phase III Clinical Trials
Johnson, M. C., Heron, C. E., Ghamrawi, R. I., Balogh, E. A., & Feldman, S. R. (2021) · Journal of Psoriasis and Psoriatic Arthritis · doi:10.1177/2475530321999087 · Cited by 8
Balato, A., Scala, E., Eyerich, K., Brembilla, N. C., Chiricozzi, A., Sabat, R., & Ghoreschi, K. (2023) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1301a16 · Cited by 8
Human bladder organoids model urinary tract infection and bacteriophage therapyPreprint
Zulk, J. J., Robertson, C. M., Ottinger, S., Kambal, A., Tostado, A. R., Fleck, R. C., Shea, A. E., Coarfa, C., Blutt, S. E., Maresso, A. W., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.30.667685 · Cited by 10
The pivotal role of Interleukin-23 in the skin-gut-joint axis
Zabotti, A., Novelli, L., Luchetti, M. M., Guggino, G., Biljan, A., Lubrano, E., & McGonagle, D. G. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103500 · Cited by 7
Integrating clinical challenges and nanotechnological based approaches for psoriasis therapy
Silvestrini, A. V. P., da Silva, U. J., Morais, M. F., Depieri, L. V., & Bentley, M. V. L. B. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214625 · Cited by 6
Zytokine der IL‐17‐Familie bei der Psoriasis
Lauffer, F., Eyerich, K., Boehncke, W., Asadullah, K., Beissert, S., Ghoreschi, K., & Schön, M. P. (2020) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14124_g · Cited by 6
Rohrbeck, A., Bruhn, V. A., Hussein, N., Hagemann, S., & Just, I. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02718-9 · Cited by 8
Studying of the interleukin-36γ expression level in the skin of patients with plaque psoriasis
Pashkin, A. Y., Zhukov, A. S., Khairutdinov, V. R., Belousova, I. E., Samtsov, A. V., & Garabagiou, A. V. (2019) · Vestnik dermatologii i venerologii · doi:10.25208/0042-4609-2019-95-4-31-39 · Cited by 5
Tang, J., Zhao, S., Su, Y., Shi, H., Li, X., Zhang, X., Wang, J., Jin, X., & He, Y. (2025) · Experimental Dermatology · doi:10.1111/exd.70128 · Cited by 7
The Act1 D10N missense variant impairs CD40 signaling in human B-cells
Yu, N., Lambert, S., Bornstein, J. J., Nair, R. P., Enerbäck, C., & Elder, J. T. (2018) · Genes and Immunity · doi:10.1038/s41435-017-0007-7 · Cited by 5
Psoriasis Skin Models as Promising Tools in Psoriasis Research
Lee, H. J. (2018) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2018.02.000760 · Cited by 5
Gao, W., Yu, B., Yan, Y., Zhao, L., & Zhao, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1151977 · Cited by 5
Epidermal Nbn deletion causes premature hair loss and a phenotype resembling psoriasiform dermatitis
Seidel, P., Remus, M., Delacher, M., Grigaravičius, P., Reuß, D., Frappart, L., von Deimling, A., Feuerer, M., Abdollahi, A., & Frappart, P. (2016) · Oncotarget · doi:10.18632/oncotarget.8470 · Cited by 6
Gkalpakiotis, S., Kojanová, M., Fialová, J., Cetkovská, P., Vašků, V., Vantuchová, Y., Machovcová, A., Gkalpakioti, P., Hrdá, P., & Arenberger, P. (2023) · Dermatology and Therapy · doi:10.1007/s13555-023-01066-z · Cited by 4
Babaei, N., Gill, M., Cervantes, M., Kim, D., Yang, S., & Wu, J. J. (2025) · Biologics · doi:10.2147/btt.s532526 · Cited by 7
Innate lymphoid cell subsets and their cytokines in autoimmune diseases
Maleki, A., Khanmiri, J. M., Khani-Eshratabadi, M., Soveyzi, F., Moazzami, B., Hamblin, M. R., & Rezaei, N. (2020) · European Cytokine Network · doi:10.1684/ecn.2020.0460 · Cited by 4
THE ROLE OF CYTOKINES OF INTERLEUKIN 36 FAMILY IN IMMUNOPATHOGENESIS OF PSORIASIS
Pashkin, A. Y., Vorob'eva, E. I., Khairutdinov, V. R., Belousova, I. E., Samtsov, A. V., & Garabagiou, A. V. (2018) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2018-2-163-170 · Cited by 7
Mi, M., Zheng, Y., Fu, X., Bao, N., Pan, L., Qin, G., & Zhao, Y. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1521544 · Cited by 3
Monteleone, G., Marafini, I., & Troncone, E. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch22 · Cited by 3
Blauvelt, A., Chiricozzi, A., & Ehst, B. D. (2020) · Current Dermatology Reports · doi:10.1007/s13671-020-00286-2 · Cited by 3
Treatment of Psoriasis by Interleukin-10 Through Impulsive Control Strategy: A Mathematical Study
Roy, A. K., & Roy, P. K. (2020) · Industrial and applied mathematics · doi:10.1007/978-981-15-0928-5_15 · Cited by 3
Adbullah, T. H., Latif, I. I., & Ibrahim, K. K. (2020) · Diyala Journal of Medicine · doi:10.26505/djm.19015031015 · Cited by 3
Immune-related hub genes and their role in psoriasis pathogenesis
Yin, T., Zhang, T., & Ma, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-02822-1 · Cited by 9
Role of IL-17 cytokines in tubal fibrosis and infertility due to salpingitis
Zhao, J., & Liu, L. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11199-3 · Cited by 2
The tissue-specific regulation of immunobiology by IL-17 signaling
Li, Y., Vyas, S., Dráber, P., Bechara, R., & Gaffen, S. L. (2026) · Science Immunology · doi:10.1126/sciimmunol.adq6406 · Cited by 2
Li, W., Wang, H., Yu, H., Wang, J., Song, X., Liu, Z., Liu, J., Hu, L., Li, H., Wang, D., et al. (2019) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22413 · Cited by 2
Cheng, X., Hu, D., Wang, C., Lu, T., Ning, Z., Li, K., Ren, Z., Huang, Y. X., Zhou, L., Chung, S. K., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00311 · Cited by 3
Mao, J., Ma, X., Sun, Y., Wang, W., & Li, B. (2025) · Cell Biology International · doi:10.1002/cbin.70024 · Cited by 2
Wang, Z., Nie, H., Fan, X., Wang, M., Chen, W., Huang, Q., Xiao, J., & Wang, W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0322602 · Cited by 3
Comprehensive analysis of transcriptome and pathway interactions in periodontitis
Gurgel, B. C. D. V., Vilela, N., Soares, K. H., Juliasse, L. E. R., Aukhil, I., & Duarte, P. M. (2025) · Journal of Applied Oral Science · doi:10.1590/1678-7757-2025-0396 · Cited by 3
Diacerein in the treatment of chronic plaque psoriasis
Baxi, K., Majmundar, D., Patel, A., Chandibhamar, V., Patel, N. M., & Majmundar, V. (2022) · Indian Journal of Drugs in Dermatology · doi:10.4103/ijdd.ijdd_19_21 · Cited by 2
Effect of Prunus yedoensis Matsumura extract on the gene expression in HaCaT cells
Joo, S.-Y., Ha, Y., Seo, D. Y., Seo, G. Y., Kim, Y., & Choi, H.-Y. (2018) · Molecular & Cellular Toxicology · doi:10.1007/s13273-018-0037-x · Cited by 2
Mechanisms of Psoriatic Plaque Formation in Mice
Wohn, C. R. (2015) · RePub (Erasmus University Rotterdam) · Cited by 4
Garcia, E. M., Lenz, J. D., Hackett, K. T., Salgado‐Pabón, W., & Dillard, J. P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.28.518270 · Cited by 2
Causal Relationship of Skin Microbiota on Psoriasis: A Mendelian Randomization Study
Chen, Y., Zhuang, Z., & Rao, Z. (2024) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s484366 · Cited by 1
Krueger, J. G., Morita, A., Uchida‐Yamada, M., Tateishi, C., Ogawa, E., Masuda, K., Yamaguchi, Y., Hur, H. B., Garcet, S., Shishido-Takahashi, N., et al. (2025) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2025.09.005 · Cited by 1
Zhang, M., Wei, Y., Yang, B., Wang, H., Dai, W., & Yang, X. (2025) · Clinical Rheumatology · doi:10.1007/s10067-025-07723-2 · Cited by 1
Zhang, Y. Z., Wen, Y., Yang, L., Xie, Y.-Z., Weng, D., Shen, X.-Y., Ma, J.-G., Lu, H., Sun, X.-L., Gu, S.-Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67769-3 · Cited by 2
Ekzematisierte Psoriasis – eine häufige, aber oft vernachlässigte Variante der Plaque‐Psoriasis
Lauffer, F., & Eyerich, K. (2023) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14991_g · Cited by 3
Targeting the IL-17/IL-23 Axis in Chronic Inflammatory Immune-Mediated Diseases
Tsoukas, A., Goodyear, C. S., & McInnes, I. B. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397933-9.00028-x · Cited by 4
Biological Drugs in Rheumatoid Disease
Uchikawa, M., & 北村, 登. (2021) · Journal of Nihon University Medical Association · doi:10.4264/numa.80.4_203 · Cited by 1
Pharmacological applications of diacerein: A review
Roy, T., Chowdhury, R. R., Chakraborty, P., Dey, S., & Chatterjee, T. K. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns1.7965 · Cited by 3
Lai, Y., & Dong, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.10014-1 · Cited by 1
The role of IL-33 and IL-17 family cytokines in periodontal disease
Awang, R. A. (2014) · Enlighten: Theses (The University of Glasgow) · Cited by 3
Macrophage INSIG1 deficiency drives psoriasiform dermatitis via the SREBP2-STAT1 axis
Li, X., Zang, Y., Li, X., Sheng, T., Liu, S., Chen, L., Xu, X., Wang, L., Long, R., Zhang, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73278-8 · Cited by 1
The role of IL-36γ/IL-1F9 in developing erythroderma in patients with psoriasis
Zaslavskiy, D. V., Chuprov, I. N., Абдикахарович, С. А., Ibragimov, K. U., Wolkenstein, P., Skrek, S. V., & Nasyrov, R. A. (2015) · Kazan medical journal · doi:10.17750/kmj2015-080
The Aetiopathogenesis of Psoriasis in 2014: An Update
Meglio, P. D., & Mak, R. K. H. (2014) · EMJ Dermatology · doi:10.33590/emjdermatol/10312377
Antimicrobial expression in keratinocytes
Björnsdóttir, E. Ö. (2016)
Aono, Y., Amano, T., Matsudo, H., Hirose, S., Morishige, T., Kikuta, N., Okada, H., & Hamaura, N. (2016) · Folia Pharmacologica Japonica · doi:10.1254/fpj.148.205
Multifactorial Diseases with Immunological Involvement
Xiao, T., Chen, H., Gao, J., Wang, G., Cizenski, J. D., Gou, D., Menter, A., Zhao, L., Yan, R., Wu, Y., et al. (2016) · Springer eBooks · doi:10.1007/978-94-024-0902-4_10
Immunohistochemical Detection of Lipocalin 2 Specific Receptor in Psoriasis
Sayar, H., Özyurt, K., Karabulut, Ş., DOĞAN, P. Ö., Seringeç, N., & Silay, E. (2015) · Turkish Journal of Dermatology · doi:10.4274/tdd.2357
Immunopathology of Psoriasis and IL-17
Tada, Y. (2017) · The Nishinihon Journal of Dermatology · doi:10.2336/nishinihonhifu.79.219
Gene regulation in psoriatic keratinocytes: microRNAs and cytokine responses
Srivastava, A. (2018) · Figshare · Cited by 1
Studies of the Systemic Inflammation in Psoriasis
Sigurdardottir, G. (2018) · Linköping University medical dissertations · doi:10.3384/diss.diva-151988
Experimental models of dermatological diseases
Sergeeva, O. N., Аксененко, М. Б., Fefelova, Y. A., Sergeeva, E. Y., & Ruksha, T. G. (2019) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2019-3-203-213
Effects of IL-17 on Epidermal Development
Sato, E., & Imafuku, S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.101602
A Case of Refractory Pustular Psoriasis Successfully Treated with Multidrug Therapy Using Brodalumab
Inoue, K., Mari, O. D. A., Takeuchi, S., & Furue, M. (2022) · The Nishinihon Journal of Dermatology · doi:10.2336/nishinihonhifu.84.24
Silfvast‐Kaiser, A., Kivelevitch, D. N., Paek, S. Y., & Menter, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-54859-9_21
Current experimental models of psoriasis
Akhmatova, E. A., & Sorokina, E. V. (2022) · Russian Journal of Clinical Dermatology and Venereology · doi:10.17116/klinderma202221061738
Right Treatment to the Right Patient in Moderate-to-Severe Psoriasis: Discussion on Difference
Woods, K. E. (2019) · EMJ Dermatology · doi:10.33590/emjdermatol/10310158
Advancing Science: Driving Progress Today for a Clearer Tomorrow
Heyraud, S. (2017) · EMJ Dermatology · doi:10.33590/emjdermatol/10311864
Rickard, G. (2018) · EMJ Dermatology · doi:10.33590/emjdermatol/10310148
IL-23 Inhibition: From Pathophysiological Jungle to Clinical Clearance
Breuer, M. E. (2019) · EMJ Dermatology · doi:10.33590/emjdermatol/10311675
da Costa, L. C. O. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2023.tde-08052023-111021
Li, Y., Cai, J., & Chong, H. (2024) · Research Square · doi:10.21203/rs.3.rs-3758249/v1
WITHDRAWN: IL-17C plays a role in the pathophysiology of acute recurrent tonsillitisPreprint
Clapperton, M., Kunanandam, T., Florea, C. D., Cunningham, M., Douglas, C. M., & McConnell, G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.08.578879
The Role Of Interleukin-17 In The Development And Severity Of Psoriasis
Abed, N. K., Ali, B. R., Munshid, M. C., & Al-fahham, A. A. (2024) · INTERNATIONAL JOURNAL OF HEALTH & MEDICAL RESEARCH · doi:10.58806/ijhmr.2024.v3i3n03
Research Progress of the Treatment of Plaque Psoriasis with Bimekizumab
张, 昕. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1451697
Metadata
- Authors
- Johnston, A., Fritz, Y., Dawes, S. M., Diaconu, D., Al-Attar, P. M., Guzman, A. M., Chen, C. S., Fu, W., Gudjonsson, J. E., McCormick, T. S., & Ward, N. L.
- Affiliations
- University of Michigan (US)
- Case Western Reserve University (US)
- University Hospitals of Cleveland (US)
- Corresponding author
- Johnston, Andrew
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-01
- Volume
- 190
- Issue
- 5
- Pages
- 2252-2262
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3577967
- OpenAlex
- W2121900420
- Cited by
- 308
- References
- 37
- Citations by year
- 2026: 6 · 2025: 20 · 2024: 20 · 2023: 22 · 2022: 25 · 2021: 36 · 2020: 29 · 2019: 23 · 2018: 29 · 2017: 24 · 2016: 24 · 2015: 23 · 2014: 19 · 2013: 7
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P50AR055508, P30AR039750, P50AR05508, P30 AR39750, R01AR062546, R01AR063437, K08AR060802)
- Janssen Research and Development
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
- Keywords
- IL-17C, psoriasis, keratinocytes, IL-17A, TNF-α, endothelial cells, epidermal hyperplasia, angiogenesis, S100A8/A9, Th17 cells, IL-23, etanercept, anti-TNF therapy, psoriasiform dermatitis
- MeSH terms
- Etanercept, Adolescent, Adult, Aged, Animals, Anti-Inflammatory Agents, Non-Steroidal, Humans, Immunoglobulin G, Inflammation, Mice, Transgenic, Middle Aged, Psoriasis, Skin, Tumor Necrosis Factor-alpha, Signal Transduction, Keratinocytes, Gene Expression, Receptors, Tumor Necrosis Factor, Interleukin-17, Endothelial Cells, Mice, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.